News & Trends - MedTech & Diagnostics
Ramsay Health Care to build $133m private hospital in Melbourne

MedTech News: Ramsay Health Care has committed to constructing and operating a new $133m greenfield private hospital in Victoria to service one of the fastest growing populations in Australia.
Northern Private Hospital will be built in Epping, which is the last major growth corridor in Victoria without a private hospital. It will be co-located with a 500-bed public hospital to ensure patients have access to a comprehensive range of health care services.
Northern Private Hospital will be built on land adjacent to the Northern Hospital, which has one of the busiest emergency departments in the state and is itself undergoing a major rebuilding and refurbishment project.
The new Northern Private Hospital will deliver extensive medical, surgical and mental health services. Patients will be able to access a broad range oftreatments in specialties such as general medicine, cardiology, vascular, orthopaedics, plastics, ENT, general surgery, gynaecology, urology, oncology, haematology, ophthalmology and gastroenterology.
The Victorian Government has also supported the construction of a link bridge to connect the private and public hospitals for ease of access between the two facilities.
Ramsay plans to open Northern Private Hospital in two stages, with the first stage to be completed in 2024 and the second stage forecast to open in 2027.
Ramsay Health Care Australia’s Chief Business Development Officer, Alex Belcastro, said this exciting announcement is the culmination of three years of extensive planning and approvals.
“This development is widely considered to be the most meaningful greenfield growth opportunity in Victoria and will offer patients in Melbourne’s northern suburbs access to high-quality health care in a private setting close to their homes,” Ms Belcastro said.
“The City of Whittlesea’s population is forecast to grow by 71% between 2018 and 2041, so this will provide much-needed treatment options for people living in these communities.”
News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board
Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]
MoreNews & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech
MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]
MoreNews & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?
Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]
More